论文部分内容阅读
1991年4～12月,我们对临床确诊的100例急性肠炎患者,用上海第一制药厂生产的盐酸山茛菪碱(654-2)注射液进行口服治疗,疗效甚佳,现报告如下。临床资料一、一般情况随机分654-2治疗组和常规治疗对照组,每组100例。 1.治疗组:男性74例,女性26例。每日腹泻次数≥8次者86例,<8次者14例。发病年龄10岁以下20例,11～20岁74例,21岁以上6例。 2.对照组:男性76例,女性24例。每日腹泻次数≥8次者81例,<8次者19例。发病年龄10岁以下17例,11～20岁79例,21岁以上4例。二、治疗方法对照组用黄连素0.3g、庆大霉素4×10.U、维生素B_120mg口服,3/d;治疗组除上药外,加用654-2 10mg口服,2/d。以上均在空腹时服药。
From April to December 1991, 100 oral acute enteritis patients diagnosed clinically were treated orally with anisodamine hydrochloride (654-2) produced by Shanghai No. 1 Pharmaceutical Factory. The results are as follows. Clinical data First, the general situation of randomized 654-2 treatment group and conventional treatment control group, 100 cases in each group. 1. Treatment group: 74 males and 26 females. The number of daily diarrhea ≥ 8 times in 86 cases, <8 times in 14 cases. The incidence of age 10 years old in 20 cases, 11 to 20 years in 74 cases, 21 years of age in 6 cases. The control group: 76 males and 24 females. 81 cases of daily diarrhea ≥ 8 times, <8 times in 19 cases. The age of onset under the age of 10 in 17 cases, 11 to 20 years in 79 cases, 21 cases of 4 cases. Second, the treatment group with berberine 0.3g, gentamicin 4 × 10. U, vitamin B_120mg orally, 3 / d; addition to the treatment group, plus 654-2 10mg orally, 2 / d. The above are fasting medication.